Eve Biomedical Inc Profile last edited on: 3/28/16
CAGE: 54X09
UEI:
Business Identifier: Gene sequencing equipment 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 14
County: San Mateo
Congr. District: 14
County: San Mateo
Public Profile
Eve Biomedical produces high-speed, low-cost, gene sequencing equipment for medical applications. Current gene sequencing solutions require expensive equipment ($100K+) and are expensive per sample ($10K+). Eve can do gene sequencing for $1K/sample on <$10K equipment. The company is developing solutions to enable genomic and personalized medicine. The technology being developed by Eve is based on the work of Eve's founder, Dr. Theofilos Kotseroglou. Dr. Kotseroglou is a pioneer in the fields of lasers, fiber-optics, and genetic analysis using microarrays. He holds five patents and is the author of numerous scientific publications.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
Less than .5MVC funded?
YesPublic/Private
Privately HeldStock Info
----IP Holdings
15-19Awards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 2015 | 2 | NIH | $499,537 | |
| Project Title: Sequencing by Transcription Using Single-Molecule Field-Effect Transistors | ||||
| 2014 | 2 | NIH | $493,162 | |
| Project Title: Accurate, Long Read Length, Whole Human Genome Sequencing Under $100 | ||||
Key People / Management
Theofilos Kotseroglou
Company News
There are no news available.
